secwatch.observer — SEC 8-K summary
======================================

Issuer:     Adagio Medical Holdings, Inc. (ADGM)
CIK:        0002006986
Form:       8-K
Filed at:   2025-04-02T23:59:59+00:00
Accession:  0001104659-25-031255
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adagio Medical reports FY2024 revenue up 101% to $0.6M, net loss widens to $75M, appoints CBO
--------------------------------------------------------------------------------

- Full year revenue $0.6M (+101% YoY); net loss $75.0M vs $36.6M prior year, driven by $49.2M impairment charge.
- Q4 revenue $137K (+76% YoY); net loss $57.4M vs $8.6M; gross margin negative 1012%.
- Cash and short-term investments $20.6M as of Dec 31, 2024.
- FULCRUM-VT pivotal study enrollment over 40%; completion target H2 2025.
- Appointed Deborah Kaster as Chief Business Officer, effective March 31, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2006986/000110465925031255/0001104659-25-031255-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2006986/000110465925031255/tm2511083d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-031255

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer